PMC:7253482 / 21844-22048 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"715","span":{"begin":142,"end":148},"obj":"Chemical"},{"id":"738","span":{"begin":191,"end":197},"obj":"Chemical"},{"id":"756","span":{"begin":21,"end":33},"obj":"Chemical"},{"id":"757","span":{"begin":81,"end":87},"obj":"Chemical"}],"attributes":[{"id":"A715","pred":"tao:has_database_id","subj":"715","obj":"MESH:D011134"},{"id":"A738","pred":"tao:has_database_id","subj":"738","obj":"MESH:D011134"},{"id":"A757","pred":"tao:has_database_id","subj":"757","obj":"MESH:D011134"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"shield densities and oligomannose abundance, which underscores the importance of glycan shielding in immune evasion.\nFig. 6 Comparison of the glycan shields of viral class I fusion proteins.\nGlycan shield"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T126","span":{"begin":181,"end":189},"obj":"Body_part"}],"attributes":[{"id":"A126","pred":"fma_id","subj":"T126","obj":"http://purl.org/sig/ont/fma/fma67257"}],"text":"shield densities and oligomannose abundance, which underscores the importance of glycan shielding in immune evasion.\nFig. 6 Comparison of the glycan shields of viral class I fusion proteins.\nGlycan shield"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T224","span":{"begin":181,"end":189},"obj":"Chemical"},{"id":"T225","span":{"begin":191,"end":197},"obj":"Chemical"}],"attributes":[{"id":"A224","pred":"chebi_id","subj":"T224","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"},{"id":"A225","pred":"chebi_id","subj":"T225","obj":"http://purl.obolibrary.org/obo/CHEBI_18154"}],"text":"shield densities and oligomannose abundance, which underscores the importance of glycan shielding in immune evasion.\nFig. 6 Comparison of the glycan shields of viral class I fusion proteins.\nGlycan shield"}

{"project":"LitCovid-sample-Enju","denotations":[{"id":"T83252","span":{"begin":0,"end":6},"obj":"NN"},{"id":"T44453","span":{"begin":7,"end":16},"obj":"NNS"},{"id":"T12305","span":{"begin":17,"end":20},"obj":"CC"},{"id":"T84841","span":{"begin":21,"end":33},"obj":"NN"},{"id":"T65772","span":{"begin":34,"end":43},"obj":"NN"},{"id":"T36713","span":{"begin":43,"end":44},"obj":"-COMMA-"},{"id":"T36054","span":{"begin":45,"end":50},"obj":"WDT"},{"id":"T54589","span":{"begin":51,"end":62},"obj":"VBZ"},{"id":"T77386","span":{"begin":63,"end":66},"obj":"DT"},{"id":"T8708","span":{"begin":67,"end":77},"obj":"NN"},{"id":"T99300","span":{"begin":78,"end":80},"obj":"IN"},{"id":"T3158","span":{"begin":81,"end":87},"obj":"NN"},{"id":"T44352","span":{"begin":88,"end":97},"obj":"NN"},{"id":"T8441","span":{"begin":98,"end":100},"obj":"IN"},{"id":"T91196","span":{"begin":101,"end":107},"obj":"JJ"},{"id":"T54044","span":{"begin":108,"end":115},"obj":"NN"},{"id":"T60202","span":{"begin":117,"end":121},"obj":"NNP"},{"id":"T35932","span":{"begin":122,"end":123},"obj":"CD"},{"id":"T52424","span":{"begin":124,"end":134},"obj":"NN"},{"id":"T33530","span":{"begin":135,"end":137},"obj":"IN"},{"id":"T64406","span":{"begin":138,"end":141},"obj":"DT"},{"id":"T54237","span":{"begin":142,"end":148},"obj":"NN"},{"id":"T17551","span":{"begin":149,"end":156},"obj":"NNS"},{"id":"T16798","span":{"begin":157,"end":159},"obj":"IN"},{"id":"T41253","span":{"begin":160,"end":165},"obj":"JJ"},{"id":"T25202","span":{"begin":166,"end":171},"obj":"NN"},{"id":"T14464","span":{"begin":172,"end":173},"obj":"CD"},{"id":"T85420","span":{"begin":174,"end":180},"obj":"NN"},{"id":"T28685","span":{"begin":181,"end":189},"obj":"NNS"},{"id":"T57548","span":{"begin":191,"end":197},"obj":"NN"},{"id":"T11420","span":{"begin":198,"end":204},"obj":"NN"}],"relations":[{"id":"R29839","pred":"arg1Of","subj":"T44453","obj":"T83252"},{"id":"R10069","pred":"arg1Of","subj":"T44453","obj":"T12305"},{"id":"R27313","pred":"arg2Of","subj":"T65772","obj":"T12305"},{"id":"R9103","pred":"arg1Of","subj":"T65772","obj":"T84841"},{"id":"R69204","pred":"arg2Of","subj":"T8708","obj":"T54589"},{"id":"R98159","pred":"arg1Of","subj":"T8708","obj":"T77386"},{"id":"R79407","pred":"arg1Of","subj":"T8708","obj":"T99300"},{"id":"R14360","pred":"arg2Of","subj":"T44352","obj":"T99300"},{"id":"R34991","pred":"arg1Of","subj":"T44352","obj":"T3158"},{"id":"R57681","pred":"arg1Of","subj":"T8708","obj":"T8441"},{"id":"R13730","pred":"arg2Of","subj":"T54044","obj":"T8441"},{"id":"R62925","pred":"arg1Of","subj":"T54044","obj":"T91196"},{"id":"R76184","pred":"arg1Of","subj":"T52424","obj":"T60202"},{"id":"R82223","pred":"arg1Of","subj":"T60202","obj":"T35932"},{"id":"R65192","pred":"arg1Of","subj":"T52424","obj":"T33530"},{"id":"R2936","pred":"arg2Of","subj":"T17551","obj":"T33530"},{"id":"R40383","pred":"arg1Of","subj":"T17551","obj":"T64406"},{"id":"R14742","pred":"arg1Of","subj":"T17551","obj":"T54237"},{"id":"R32039","pred":"arg1Of","subj":"T17551","obj":"T16798"},{"id":"R39868","pred":"arg2Of","subj":"T28685","obj":"T16798"},{"id":"R21190","pred":"arg1Of","subj":"T28685","obj":"T41253"},{"id":"R2149","pred":"arg1Of","subj":"T28685","obj":"T25202"},{"id":"R57572","pred":"arg1Of","subj":"T28685","obj":"T14464"},{"id":"R86331","pred":"arg1Of","subj":"T28685","obj":"T85420"}],"text":"shield densities and oligomannose abundance, which underscores the importance of glycan shielding in immune evasion.\nFig. 6 Comparison of the glycan shields of viral class I fusion proteins.\nGlycan shield"}

{"project":"LitCovid-sample-PD-FMA","denotations":[{"id":"T125","span":{"begin":181,"end":189},"obj":"Body_part"}],"attributes":[{"id":"A125","pred":"fma_id","subj":"T125","obj":"http://purl.org/sig/ont/fma/fma67257"}],"text":"shield densities and oligomannose abundance, which underscores the importance of glycan shielding in immune evasion.\nFig. 6 Comparison of the glycan shields of viral class I fusion proteins.\nGlycan shield"}

{"project":"LitCovid-sample-CHEBI","denotations":[{"id":"T154","span":{"begin":181,"end":189},"obj":"Chemical"},{"id":"T155","span":{"begin":191,"end":197},"obj":"Chemical"}],"attributes":[{"id":"A154","pred":"chebi_id","subj":"T154","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"},{"id":"A155","pred":"chebi_id","subj":"T155","obj":"http://purl.obolibrary.org/obo/CHEBI_18154"}],"text":"shield densities and oligomannose abundance, which underscores the importance of glycan shielding in immune evasion.\nFig. 6 Comparison of the glycan shields of viral class I fusion proteins.\nGlycan shield"}

{"project":"LitCovid-sample-sentences","denotations":[{"id":"T126","span":{"begin":117,"end":190},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"shield densities and oligomannose abundance, which underscores the importance of glycan shielding in immune evasion.\nFig. 6 Comparison of the glycan shields of viral class I fusion proteins.\nGlycan shield"}

{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"756","span":{"begin":21,"end":33},"obj":"Chemical"},{"id":"757","span":{"begin":81,"end":87},"obj":"Chemical"},{"id":"715","span":{"begin":142,"end":148},"obj":"Chemical"}],"attributes":[{"id":"A757","pred":"pubann:denotes","subj":"757","obj":"MESH:D011134"},{"id":"A715","pred":"pubann:denotes","subj":"715","obj":"MESH:D011134"}],"text":"shield densities and oligomannose abundance, which underscores the importance of glycan shielding in immune evasion.\nFig. 6 Comparison of the glycan shields of viral class I fusion proteins.\nGlycan shield"}

{"project":"LitCovid-sample-PD-GO-BP-0","denotations":[{"id":"T42","span":{"begin":101,"end":115},"obj":"http://purl.obolibrary.org/obo/GO_0020012"},{"id":"T43","span":{"begin":101,"end":115},"obj":"http://purl.obolibrary.org/obo/GO_0051805"}],"text":"shield densities and oligomannose abundance, which underscores the importance of glycan shielding in immune evasion.\nFig. 6 Comparison of the glycan shields of viral class I fusion proteins.\nGlycan shield"}

{"project":"LitCovid-sample-GO-BP","denotations":[{"id":"T39","span":{"begin":101,"end":115},"obj":"http://purl.obolibrary.org/obo/GO_0042783"}],"text":"shield densities and oligomannose abundance, which underscores the importance of glycan shielding in immune evasion.\nFig. 6 Comparison of the glycan shields of viral class I fusion proteins.\nGlycan shield"}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T43","span":{"begin":101,"end":115},"obj":"http://purl.obolibrary.org/obo/GO_0042783"}],"text":"shield densities and oligomannose abundance, which underscores the importance of glycan shielding in immune evasion.\nFig. 6 Comparison of the glycan shields of viral class I fusion proteins.\nGlycan shield"}

{"project":"LitCovid-sentences","denotations":[{"id":"T126","span":{"begin":117,"end":190},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"shield densities and oligomannose abundance, which underscores the importance of glycan shielding in immune evasion.\nFig. 6 Comparison of the glycan shields of viral class I fusion proteins.\nGlycan shield"}